news - International Biopharmaceutical Industry

Current Edition

news

Amgen, Novartis’ closely watched migraine drug approved

Amgen and Novartis on Thursday secured Food and Drug Administration approval for Aimovig, the first regulatory thumbs up for a new class of migraine treatments ca...

21 May 2018 news Amgen | approved

Continue Reading →

news

8,000 biopharma job opportunities if Ireland has the ambition

NIBRT CEO Dominic Carolan on stage at BioPharma Ambition 2018. Image: Luke Maxwell Ireland is at the forefro...

21 May 2018 news ambition | biopharma

Continue Reading →

news

Franco-Quebecois Forum for Health Innovation (FFQIS): successful second edition strengthens international partnerships

With a focus on medical imaging, digital health, biomaterials and biomechanics, the event, promoting knowledge sharing and B2B meetings, took place on May 15 and 16 i...

17 May 2018 news FFQIS | Franco-Quebecois

Continue Reading →

news

Bavarian Nordic Announces Acceptance of Abstracts and Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting

Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the acceptance of 4 poster presentations and one podium presentation at the American Society of Clinical O...

17 May 2018 news Abstracts | Acceptance

Continue Reading →

news

HKBU team develops metal-based probes for detecting cancer biomarkers

The discovery has enhanced the understanding of dopamine receptors in carcinogenesis A team at Hong Kong Baptist University has developed the world’s first iridiu...

17 May 2018 news biomarkers | cancer

Continue Reading →

news

Shuwen Debuts it’s CODAR-ARMS PCR Liquid Biopsy Technology at ASCO 2018

Shuwen Biotech, a leading provider of innovative diagnostic products and medical diagnostic services, announced that studies based on its proprietary high-sensitivity...

17 May 2018 news Biopsy | Biotech

Continue Reading →

news

Roche’s TECENTRIQ (Atezolizumab) Receives Priority Review

The new immunotherapy is being developed for the treatment of metastatic non-squamous non-small cell lung cancer. According to the International Agency for Research ...

16 May 2018 news Atezolizumab | priority

Continue Reading →

news

AGC Biologics Enters into Commercial Supply Agreement with MacroGenics

AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that in late 2017 it entered into a commercial sup...

16 May 2018 news AGC | agreement

Continue Reading →

news

Vyriad signs a contract with IBM to build an oncolytic virus anti-cancer vaccines manufacturing facility

The custom buildout will be financed with proceeds from a recently completed $9 million secured convertible note financing, which included participation by Mayo Clini...

14 May 2018 news build | contract

Continue Reading →

news

Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine

(‘Emergex’), a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, today announces that Innovate UK, the UK’s ...

14 May 2018 news awarded | Emergex

Continue Reading →